Global Vocal Biomarkers Market growth is driven by rising adoption of artificial intelligence in healthcare, increasing prevalence of neurological and mental health disorders, and growing demand for ...

The European voice/vocal biomarker market is positioned for substantial growth, reaching $1.69 billion by 2035 from $335.2 million in 2024, at a CAGR of 16%. Utilized for non-invasive health ...

Ibex's high-performance AI platform--already deployed across more than 50 health systems worldwide and used in collaboration with major industry organizations such as Philips and Roche--now supports ...

Biomarkers are quantifiable compounds that can determine human health status and potentially detect the presence of disease in the body. In clinical settings, routine procedures detect, measure, and ...

Image Analysis Group and Ferring validate AI imaging biomarkers with FCI and Dexeus to optimize conception timing and personalize fertility care. Image-centric AI collaboration between Image Analysis ...

The Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine’s Center for Space Medicine, with consortium partners California Institute of Technology and Massachusetts ...

Jonathan Thompson, MD, MS, emphasized that comprehensive biomarker testing with next-generation sequencing and PD-L1 analysis—implemented as reflex testing at biopsy—is essential to guide precision ...

The identification of unique pulmonary fibrosis endotypes is an important step in the development of precision medicine approaches for the incurable condition. Three distinct blood biomarker ...

Results from a Phase 1 study of GT-02287 in healthy volunteers demonstrated favorable safety and tolerability, plasma and CNS exposures in the projected therapeutic range, and target engagement with ...